Literature DB >> 7102399

Extensive evacuation of subarachnoid clot for prevention of vasospasm--effective or not?

H Ohta, Z Ito, N Yasui, A Suzuki.   

Abstract

The effect of subarachnoid haematoma (clot) evacuation for the prevention of vasospasm (VS) in the acute state was studied using 62 ruptured IC and MC aneurysm cases. Extensive clot evacuation within 48 hours after the onset did not prevent the development of VS but reduced the severity of VS, especially in the main trunks of the cerebral arteries (IC, M1, M2, A1). But excessive clot evaluation applied to the angry, swollen brain in the acute stage worsened the brain swelling and sometimes formed an intracerebral haematoma due to brain compression. The extent of the clot evacuation should be determined by preoperative CT findings and the brain's condition during the operation.

Entities:  

Mesh:

Year:  1982        PMID: 7102399     DOI: 10.1007/BF01728862

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  3 in total

1.  [Cerebral infraction due to vasospasm, revealed by computed tomography (author's transl)].

Authors:  H Ohta; Z Ito
Journal:  Neurol Med Chir (Tokyo)       Date:  1981-04       Impact factor: 1.742

2.  [Computed tomography and ruptured intracranial aneurysm in acute stage (author's transl)].

Authors:  H Ohta; Z Ito; K Nakajima; A Suzuki; T Kobayashi; K Uemura; K Ishii
Journal:  Neurol Med Chir (Tokyo)       Date:  1979-04       Impact factor: 1.742

Review 3.  Attempted prevention or treatment of intracranial arterial spasm: a survey.

Authors:  R H Wilkins
Journal:  Neurosurgery       Date:  1980-02       Impact factor: 4.654

  3 in total
  10 in total

1.  Experimental basilar artery spasm caused by autologous blood application: effects of clot removal and topical nicardipine.

Authors:  R Tuncer
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

2.  Balloon catheter technique for dilatation of constricted cerebral arteries after aneurysmal SAH.

Authors:  Y N Zubkov; B M Nikiforov; V A Shustin
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

3.  Early aneurysm surgery: a 7 year clinical practice report.

Authors:  J M Gilsbach; A G Harders; H R Eggert; M E Hornyak
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

4.  Cisternal and lumbar CSF levels of arachidonate metabolites after subarachnoid haemorrhage: an assessment of the biochemical hypothesis of vasospasm.

Authors:  R Rodriguez y Baena; P Gaetani; V Silvani; T Viganò; M T Crivellari; P Paoletti
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

5.  The effect of very early cisternal irrigation on basilar artery spasm after SAH in the rat model.

Authors:  I H Aydin; A Onder
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

6.  A review of 102 consecutive patients with intracranial aneurysms in a community hospital in Japan.

Authors:  K Ohno; R Suzuki; H Masaoka; S Monma; Y Matsushima; Y Inaba
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

7.  Prevention of symptomatic vasospasm by topically applied nimodipine.

Authors:  L M Auer; Z Ito; A Suzuki; H Ohta
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

8.  The microsurgical anterior interhemispheric approach suitably applied to ruptured aneurysms of the anterior communicating artery in the acute stage.

Authors:  Z Ito
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

9.  Prevention of delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage by intrathecal bolus injection of tissue plasminogen activator (rTPA). A prospective study.

Authors:  V Seifert; D Stolke; M Zimmermann; A Feldges
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

10.  Acute surgery of cerebral aneurysms and prevention of symptomatic vasospasm.

Authors:  L M Auer
Journal:  Acta Neurochir (Wien)       Date:  1983       Impact factor: 2.216

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.